LIANI, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.154
EU - Europa 977
AS - Asia 311
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
AF - Africa 2
Totale 2.451
Nazione #
US - Stati Uniti d'America 1.152
IE - Irlanda 197
CN - Cina 172
SE - Svezia 163
IT - Italia 147
UA - Ucraina 124
GB - Regno Unito 119
FR - Francia 110
TR - Turchia 102
DE - Germania 44
IN - India 31
BE - Belgio 30
FI - Finlandia 27
AR - Argentina 3
EU - Europa 3
JP - Giappone 3
NL - Olanda 3
RU - Federazione Russa 3
VN - Vietnam 3
AT - Austria 2
CA - Canada 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
MA - Marocco 1
MT - Malta 1
PL - Polonia 1
Totale 2.451
Città #
Chandler 299
Dublin 195
Jacksonville 174
Southend 98
Ashburn 89
Princeton 73
Dearborn 70
Ann Arbor 64
Izmir 57
Nanjing 40
Chieti 34
Wilmington 32
Altamura 31
Beijing 31
Brussels 30
Cambridge 26
Nanchang 17
Washington 17
Rome 11
Boardman 10
Changsha 10
Kunming 10
Shenyang 10
Woodbridge 10
Hebei 8
New York 7
Ningbo 7
Grevenbroich 6
Jinan 6
Tianjin 6
Jiaxing 5
Norwalk 5
Seattle 5
Falls Church 4
Augusta 3
Dong Ket 3
Hangzhou 3
Hefei 3
San Vito Chietino 3
Tappahannock 3
Tokyo 3
Amsterdam 2
Ancona 2
Changchun 2
Helsinki 2
Houston 2
Lanciano 2
Lanzhou 2
L’Aquila 2
Moncalieri 2
Mountain View 2
Recanati 2
Roseto Degli Abruzzi 2
San Mateo 2
Shanghai 2
Torino 2
Alexandria 1
Athens 1
Bellante 1
Bucharest 1
Caserta 1
Catania 1
Chelmsford 1
Chengdu 1
Chongqing 1
Council Bluffs 1
Dallas 1
Duncan 1
Düsseldorf 1
Francavilla Al Mare 1
Fuzhou 1
Greifswald 1
Kraków 1
L'aquila 1
Leawood 1
London 1
Madrid 1
Medesano 1
Melita 1
Milan 1
Monmouth Junction 1
Nanping 1
Naples 1
Newcastle Upon Tyne 1
Novokuznetsk 1
Orange 1
Ottawa 1
Providence 1
Pune 1
Rabat 1
Redmond 1
Rocca San Felice 1
San Francisco 1
San Jose 1
Stockholm 1
Taiyuan 1
Tirana 1
Toronto 1
Vancouver 1
Vienna 1
Totale 1.592
Nome #
Pentraxin 3 and platelet activation in obese patients after gastric banding 103
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 99
Significance of urinary 11-dehydro-thromboxane B2 in age-related diseases: Focus on atherothrombosis 90
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 89
Platelet activation in obesity and metabolic syndrome. 86
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 86
Platelets and Diabetes 84
Arterial stiffness and sedentary lifestyle: Role of oxidative stress 82
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin 80
Platelets and diabetes mellitus 79
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 78
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: Effects of anti-TNFα treatment 77
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 76
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 76
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 75
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 75
LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro 73
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 70
Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment. 70
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 68
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 67
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 67
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 66
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 64
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 62
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 62
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 61
The Role of Platelets in Diabetes Mellitus 57
Plasma Levels Of Soluble CD36 In Type 2 Diabetes - A Link Between Platelet Activation, Inflammation And Oxidative Stress. 56
Endogenous secretory rage in obese women: association with oxidative stress and platelet activation. Proc. 112° Congr. Naz. Soc It. Med. Interna, Roma, ottobre 2011, Int Emerg Med 6(S2): S186, 2011 56
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 53
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 48
null 41
Endogenous PCSK9 may influence circulating CD45NEG/CD34BRIGHT and CD45NEG/CD34BRIGHT/CD146NEG cells in patients with type 2 Diabetes Mellitus 41
Insulin resistance and NAFLD may influence memory performance in obese patients with prediabetes or newly-diagnosed type 2 diabetes 41
Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss 35
Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. 33
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 31
Endogenous PCSK9 may influence circulating CD45neg/CD34bright and CD45neg/CD34bright/CD146neg cells in patients with type 2 diabetes mellitus 31
Sex-Specific Association of Endogenous PCSK9 With Memory Function in Elderly Subjects at High Cardiovascular Risk 29
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 25
Kinetics of Circulating Extracellular Vesicles Over the 24-Hour Dosing Interval After Low-Dose Aspirin Administration in Patients at Cardiovascular Risk 17
Study of pulsed electrostatic field (PESF) in the perfusion of peripheral tissues: Microangiopathy, nutrition and quality of perceiver life 12
null 1
Totale 2.672
Categoria #
all - tutte 8.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201981 0 0 0 0 0 0 0 0 5 3 7 66
2019/2020537 131 28 18 6 55 44 71 48 20 65 49 2
2020/2021197 32 1 37 8 5 44 14 7 12 22 6 9
2021/2022234 8 9 1 53 13 9 11 16 29 9 15 61
2022/2023770 51 109 45 75 68 132 46 84 102 13 23 22
2023/2024345 42 11 29 15 32 115 72 26 3 0 0 0
Totale 2.672